The structural biology of type III CRISPR-Cas systems

被引:3
|
作者
Li, Xuzichao [1 ]
Han, Jie [2 ]
Yang, Jie [1 ]
Zhang, Heng [1 ]
机构
[1] Tianjin Med Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr M, Sch Basic Med Sci, Dept Biochem & Mol Biol,Minist Educ,State Key Lab, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR-Cas systems; Type III CRISPR-Cas systems; Structural biology; RNA-SILENCING COMPLEX; CRYSTAL-STRUCTURE; EVOLUTIONARY CLASSIFICATION; PROTEIN CLEAVAGE; CMR COMPLEX; CSM COMPLEX; EFFECTOR; DEFENSE; SPECIFICITY; RESISTANCE;
D O I
10.1016/j.jsb.2024.108070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas system is an RNA-guided adaptive immune system widespread in bacteria and archaea. Among them, type III CRISPR-Cas systems are the most ancient throughout the CRISPR-Cas family, proving anti-phage defense through a crRNA-guided RNA targeting manner and possessing multiple enzymatic activities. Type III CRISPR-Cas systems comprise four typical members (type III-A to III-D) and two atypical members (type III-E and type III-F), providing immune defense through distinct mechanisms. Here, we delve into structural studies conducted on three well-characterized members: the type III-A, III-B, and III-E systems, provide an overview of the structural insights into the crRNA-guided target RNA cleavage, self/non-self discrimination, and the target RNA-dependent regulation of enzymatic subunits in the effector complex.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The structural biology of CRISPR-Cas systems
    Jiang, Fuguo
    Doudna, Jennifer A.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2015, 30 : 100 - 111
  • [2] Structural basis of CRISPR-Cas Type III prokaryotic defence systems
    Molina, Rafael
    Sofos, Nicholas
    Montoya, Guillermo
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2020, 65 : 119 - 129
  • [3] Compact but mighty: Biology and applications of type III-E CRISPR-Cas systems
    Steens, Jurre A.
    van der Oost, John
    Staals, Raymond H. J.
    MOLECULAR CELL, 2022, 82 (23) : 4405 - 4406
  • [4] The biology and type I/III hybrid nature of type I-D CRISPR-Cas systems
    McBride, Tess M.
    Cameron, Shaharn C.
    Fineran, Peter C.
    Fagerlund, Robert D.
    BIOCHEMICAL JOURNAL, 2023, 480 (07) : 471 - 488
  • [5] Harnessing Type I and Type III CRISPR-Cas systems for genome editing
    Li, Yingjun
    Pan, Saifu
    Zhang, Yan
    Ren, Min
    Feng, Mingxia
    Peng, Nan
    Chen, Lanming
    Liang, Yun Xiang
    She, Qunxin
    NUCLEIC ACIDS RESEARCH, 2016, 44 (04)
  • [6] A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
    Kazlauskiene, Migle
    Kostiuk, Georgij
    Venclovas, Ceslovas
    Tamulaitis, Gintautas
    Siksnys, Virginijus
    SCIENCE, 2017, 357 (6351) : 605 - +
  • [7] The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems
    Huang, Fengtao
    Zhu, Bin
    FRONTIERS IN MICROBIOLOGY, 2021, 11
  • [8] CRISPR-Cas changing biology?
    Baxter, Janella
    BIOLOGY & PHILOSOPHY, 2019, 34 (01)
  • [9] CRISPR-Cas changing biology?
    Janella Baxter
    Biology & Philosophy, 2019, 34
  • [10] Structural biology of CRISPR-Cas immunity and genome editing enzymes
    Wang, Joy Y.
    Pausch, Patrick
    Doudna, Jennifer A.
    NATURE REVIEWS MICROBIOLOGY, 2022, 20 (11) : 641 - 656